We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Inflammation-associated graft loss in renal transplant recipients.
- Authors
Dahle, Dag Olav; Mjøen, Geir; Öqvist, Björn; Scharnagl, Hubert; Weihrauch, Gisela; Grammer, Tanja; März, Winfried; Abedini, Sadollah; Norby, Gudrun E.; Holme, Ingar; Fellström, Bengt; Jardine, Alan; Holdaas, Hallvard
- Abstract
Background. Although short-term graft survival has improved substantially in renal transplant recipients, long-term graft survival has not improved over the last decades. The lack of knowledge of specific causes and risk factors has hampered improvements in long-term allograft survival. There is an uncertainty if inflammation is associated with late graft loss.Methods. We examined, in a large prospective trial, the inflammation markers high-sensitivity C-reactive protein (hsCRP) and interleukin-6 (IL-6) and their association with chronic graft dysfunction. We collected data from the Assessment of Lescol in Renal Transplant trial, which recruited 2102 maintenance renal transplant recipients.Results. Baseline values were hsCRP 3.8 ± 6.7 mg/L and IL-6 2.9 ± 1.9 pg/mL. Adjusted for traditional risk factors, hsCRP and IL-6 were independently associated with death-censored graft loss, the composite end points graft loss or death and doubling of serum creatinine, graft loss or death.Conclusion. The inflammation markers hsCRP and IL-6 are associated with long-term graft outcomes in renal transplant recipients.
- Subjects
KIDNEY transplantation; LONGITUDINAL method; C-reactive protein; INTERLEUKIN-6; CREATININE; INFLAMMATION; HEALTH outcome assessment
- Publication
Nephrology Dialysis Transplantation, 2011, Vol 26, Issue 11, p3756
- ISSN
0931-0509
- Publication type
Article
- DOI
10.1093/ndt/gfr163